Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (301-310 of 941) with videos related to

Pageof 95
Sort By:
British Journal of Urology|February 1, 1997
Early experience with high-intensity focused ultrasound for the treatment of benign prostatic hypertrophyL D Sullivan, M G McLoughlin, L G Goldenberg, et al.
Cancer Research|April 15, 1997
A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID miceN Sato, M E Gleave, N Bruchovsky, et al.
Psychotherapy Research : Journal of the Society for Psychotherapy Research|July 11, 2012
Clinical prediction in group psychotherapyChristopher L Chapman, Gary M Burlingame, Robert Gleave, et al.
Proceedings of the Royal Society of Medicine|October 5, 2010
A controlled trial of conservative treatment for early breast cancerA P Forrest, E N Gleave, M M Roberts, et al.
Cancer Medicine|October 25, 2013
Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsenBrent Blumenstein, Fred Saad, Sebastien Hotte, et al.
British Medical Journal|December 26, 1970
Benign and malignant breast disease in South Wales: a study of urinary steroidsE H Cameron, K Griffiths, E Gleave, et al.
CDR (London, England : Review)|February 1, 1991
HIV-2 in the United Kingdom--a reviewB G Evans, O N Gill, S R Gleave, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1996
[Hormone release and intermittent hormonal therapy in the LN CaP model of human prostate cancer]M Gleave, N Santo, P S Rennie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesisFrancois Lamoureux, Christian Thomas, Min-Jean Yin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1997
[In vitro and in vivo models developed from human prostatic cancer]F Bladou, M E Gleave, F Penault-Llorca, et al.
Pageof 95

Showing results (301-310 of 941) with videos related to

Sort By:
Pageof 95
British Journal of Urology|February 1, 1997
Early experience with high-intensity focused ultrasound for the treatment of benign prostatic hypertrophyL D Sullivan, M G McLoughlin, L G Goldenberg, et al.
Cancer Research|April 15, 1997
A metastatic and androgen-sensitive human prostate cancer model using intraprostatic inoculation of LNCaP cells in SCID miceN Sato, M E Gleave, N Bruchovsky, et al.
Psychotherapy Research : Journal of the Society for Psychotherapy Research|July 11, 2012
Clinical prediction in group psychotherapyChristopher L Chapman, Gary M Burlingame, Robert Gleave, et al.
Proceedings of the Royal Society of Medicine|October 5, 2010
A controlled trial of conservative treatment for early breast cancerA P Forrest, E N Gleave, M M Roberts, et al.
Cancer Medicine|October 25, 2013
Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsenBrent Blumenstein, Fred Saad, Sebastien Hotte, et al.
British Medical Journal|December 26, 1970
Benign and malignant breast disease in South Wales: a study of urinary steroidsE H Cameron, K Griffiths, E Gleave, et al.
CDR (London, England : Review)|February 1, 1991
HIV-2 in the United Kingdom--a reviewB G Evans, O N Gill, S R Gleave, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1996
[Hormone release and intermittent hormonal therapy in the LN CaP model of human prostate cancer]M Gleave, N Santo, P S Rennie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesisFrancois Lamoureux, Christian Thomas, Min-Jean Yin, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 1, 1997
[In vitro and in vivo models developed from human prostatic cancer]F Bladou, M E Gleave, F Penault-Llorca, et al.
Pageof 95